Table 1.

Baseline characteristics of the study population

Characteristic	Total (%)
Number of patients	8 (100)
Median age in years (min – max)	52.9 (32.8–74.5)
Race
Caucasian	7 (87.5)
African-American	1 (12.5)
ECOG PS
0	7 (87.5)
1	1 (12.5)
Prior systemic treatments for metastatic disease
0	6 (75)
1	2 (25)
PD-L1≥1%*	5 (62.5)

*Measured by Ventana SP142 assay.

ECOG PS, Eastern Cooperative Oncology Group performance status; PD-L1, programmed cell death ligand 1.